U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Jan 2022
Historique:
accepted: 21 06 2021
pubmed: 3 7 2021
medline: 9 2 2022
entrez: 2 7 2021
Statut: ppublish

Résumé

Our hypothesis was that high hemoglobin (Hb) level might be associated with hypercoagulable state and death due to COVID-19. Of the 9467 hospitalized COVID-19 patients, patients were subdivided into 5 groups based on the level of Hb; Hb < 10 g/dL, 10 g/dL ≤ Hb < 12 g/dL, 12 g/dL ≤ Hb < 14 g/dL, 14 g/dL ≤ Hb < 16 g/dL, and Hb ≥ 16 g/dL. Compared to patients with 12 g/dL ≤ Hb < 14 g/dL, patients with Hb ≥ 16 g/dL had significantly higher adjusted in-hospital mortality (OR [95% CI] 1.62 [1.15-2.27], P = 0.005).

Identifiants

pubmed: 34213716
doi: 10.1007/s11239-021-02516-1
pii: 10.1007/s11239-021-02516-1
pmc: PMC8250547
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-117

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Lancet. 2020 Aug 1;396(10247):320-332
pubmed: 32682491
Cardiovasc Interv Ther. 2020 Jul;35(3):209-217
pubmed: 32253719
Eur Heart J Case Rep. 2020 Nov 18;4(6):1-5
pubmed: 33623859
BMJ Case Rep. 2020 Sep 18;13(9):
pubmed: 32948531
J Thromb Haemost. 2020 Sep;18(9):2103-2109
pubmed: 32558075
Am J Cardiol. 2018 Mar 15;121(6):695-702
pubmed: 29361289
Am J Emerg Med. 2021 Oct;48:140-147
pubmed: 33895645
J Clin Med. 2019 Aug 28;8(9):
pubmed: 31466281
J Med Virol. 2021 Feb;93(2):698-701
pubmed: 32910466

Auteurs

Toshiki Kuno (T)

Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY, 10003, USA. Toshiki.Kuno@mountsinai.org.

Matsuo So (M)

Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY, 10003, USA.

Mai Takahashi (M)

Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY, 10003, USA.

Natalia N Egorova (NN)

Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH